A.H. Steinhart

1.1k total citations
19 papers, 690 citations indexed

About

A.H. Steinhart is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, A.H. Steinhart has authored 19 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 9 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in A.H. Steinhart's work include Inflammatory Bowel Disease (16 papers), Microscopic Colitis (9 papers) and Eosinophilic Esophagitis (2 papers). A.H. Steinhart is often cited by papers focused on Inflammatory Bowel Disease (16 papers), Microscopic Colitis (9 papers) and Eosinophilic Esophagitis (2 papers). A.H. Steinhart collaborates with scholars based in Canada, United States and Italy. A.H. Steinhart's co-authors include Aaron Brzezinski, Tadaaki Hiruki, J. P. Baker, Jennifer Baker, Z. Cohen, Robin S. McLeod, Michael J. Solomon, Nigel Girgrah, Gordon R. Greenberg and Mark J. Daly and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

A.H. Steinhart

18 papers receiving 667 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.H. Steinhart Canada 11 439 260 229 155 85 19 690
D. Valpiani Italy 12 589 1.3× 414 1.6× 325 1.4× 249 1.6× 88 1.0× 16 966
Maria Carla Di Paolo Italy 10 262 0.6× 138 0.5× 169 0.7× 207 1.3× 95 1.1× 23 612
Veerle Bulteel Belgium 9 323 0.7× 180 0.7× 155 0.7× 211 1.4× 36 0.4× 10 629
Cloé Charpentier France 12 502 1.1× 366 1.4× 271 1.2× 74 0.5× 68 0.8× 38 687
I A Finnie United Kingdom 9 155 0.4× 86 0.3× 168 0.7× 280 1.8× 82 1.0× 13 535
R. Morera Italy 8 180 0.4× 101 0.4× 137 0.6× 189 1.2× 40 0.5× 12 530
Klaus Kannengießer Germany 11 354 0.8× 261 1.0× 192 0.8× 119 0.8× 41 0.5× 19 675
R. Marasco Italy 11 398 0.9× 214 0.8× 168 0.7× 113 0.7× 37 0.4× 28 793
Claire E Parker Canada 8 516 1.2× 327 1.3× 159 0.7× 133 0.9× 28 0.3× 11 704
Petr Ricanek Norway 12 275 0.6× 220 0.8× 130 0.6× 218 1.4× 23 0.3× 26 578

Countries citing papers authored by A.H. Steinhart

Since Specialization
Citations

This map shows the geographic impact of A.H. Steinhart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.H. Steinhart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.H. Steinhart more than expected).

Fields of papers citing papers by A.H. Steinhart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.H. Steinhart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.H. Steinhart. The network helps show where A.H. Steinhart may publish in the future.

Co-authorship network of co-authors of A.H. Steinhart

This figure shows the co-authorship network connecting the top 25 collaborators of A.H. Steinhart. A scholar is included among the top collaborators of A.H. Steinhart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.H. Steinhart. A.H. Steinhart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Fiorino, Gionata, Ashwin N. Ananthakrishnan, Raymond K. Cross, et al.. (2025). Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease. Journal of Clinical Medicine. 14(5). 1561–1561. 1 indexed citations
2.
Ho, Kai Fai, Brian G. Feagan, Remo Panaccione, et al.. (2025). Therapeutic Drug Monitoring for Dose Optimization of Infliximab in Patients With Inflammatory Bowel Disease: An Analysis of Canadian Real‐World Data. Canadian Journal of Gastroenterology and Hepatology. 2025(1). 5713315–5713315.
3.
Zezos, Petros, Boyko Kabakchiev, Adam V. Weizman, et al.. (2017). P502 Ulcerative colitis patients on vedolizumab lacking response at induction phase continue to improve over the first 6 months of treatment. Journal of Crohn s and Colitis. 11(suppl_1). S334–S335. 2 indexed citations
4.
Labbé, Catherine, Philippe Goyette, Christine Lefebvre, et al.. (2008). MAST3: a novel IBD risk factor that modulates TLR4 signaling. Genes and Immunity. 9(7). 602–612. 25 indexed citations
5.
Sands, Bruce E., et al.. (2003). Optimal Crohn's disease activity index (CDAI) response criteria is defined by decreaseȦ100 points. Gastroenterology. 124(4). A206–A206. 9 indexed citations
6.
Silverberg, Mark S., Catherine L. Clelland, Janet E. Murphy, et al.. (2001). Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin. Human Genetics. 108(3). 205–210. 6 indexed citations
7.
Steinhart, A.H., et al.. (1998). Patients’ Perceptions of their Participation in a Clinical Trial for Postoperative Crohn’s Disease. Canadian Journal of Gastroenterology and Hepatology. 12(4). 287–291. 10 indexed citations
8.
Rioux, John D., Mark J. Daly, Valerie Stone, et al.. (1998). Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16. Gastroenterology. 115(5). 1062–1065. 56 indexed citations
9.
Girgrah, Nigel, Robin S. McLeod, & A.H. Steinhart. (1998). Reliability of a cronh's disease clinical classification scheme based on disease behaviour. Gastroenterology. 114(3). A985–A985. 42 indexed citations
10.
Silverberg, Mark S., A.H. Steinhart, Robin S. McLeod, et al.. (1998). Contribution of HLA class II genes to susceptibility to ulcerative colitis (UC) in a Canadian inflammatory bowel disease (IBD) population. Gastroenterology. 114. A1085–A1085. 1 indexed citations
11.
Silverberg, Mark S., et al.. (1998). Low bone mineral density (BMD) in Crohn's disease (CD) occurs independent of corticosteroid use. Gastroenterology. 114. A1086–A1086. 4 indexed citations
12.
Steinhart, A.H., Keith O’Rourke, Andrews Df, et al.. (1997). Risk and significance of endoscopic/radiological evidence of recurrent Crohn's disease. Gastroenterology. 113(6). 1823–1827. 68 indexed citations
13.
Maunder, Robert, Brenda B. Toner, Gordon R. Greenberg, et al.. (1997). Health‐Related Concerns of People who Receive Psychological Support for Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology. 11(8). 681–685. 38 indexed citations
14.
Steinhart, A.H., Tadaaki Hiruki, Aaron Brzezinski, & J. P. Baker. (1996). Treatment of left‐sided ulcerative colitis with butyrate enemas: a controlled trial. Alimentary Pharmacology & Therapeutics. 10(5). 729–736. 176 indexed citations
15.
Steinhart, A.H., Tadaaki Hiruki, Aaron Brzezinski, & J. P. Baker. (1995). Treatment of left-sided ulcerative colitis with butyrate enemas: A randomized controlled trial. Gastroenterology. 108(4). A921–A921. 11 indexed citations
16.
Greenbloom, Susan, et al.. (1995). Total enteral immunomodulatory nutrition (TEIN) treatment for severe active ulcerative colitis. Gastroenterology. 108(4). A827–A827. 9 indexed citations
17.
Steinhart, A.H., Aaron Brzezinski, & Jennifer Baker. (1994). Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas.. PubMed. 89(2). 179–83. 116 indexed citations
18.
Solomon, Michael J., et al.. (1993). Combination of Ciprofloxacin and Metronidazole in Severe Perianal Crohn’s Disease. SHILAP Revista de lepidopterología. 7(7). 571–573. 98 indexed citations
19.
Steinhart, A.H., et al.. (1992). Effect of dietary fiber on total carbohydrate losses in ileostomy effluent.. PubMed. 87(1). 48–54. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Valpiani Breakdown of academic impact, for papers by Maria Carla Di Paolo Breakdown of academic impact, for papers by Veerle Bulteel Breakdown of academic impact, for papers by Cloé Charpentier Breakdown of academic impact, for papers by I A Finnie Breakdown of academic impact, for papers by R. Morera Breakdown of academic impact, for papers by Klaus Kannengießer Breakdown of academic impact, for papers by R. Marasco Breakdown of academic impact, for papers by Claire E Parker Breakdown of academic impact, for papers by Petr Ricanek
Rankless by CCL
2026